UroGen Gets A First-Ever Bladder Cancer Approval Despite US FDA AdComm ‘No’ Vote

 
• By Joseph Haas
  
Stamp saying approved
Despite advisory committee setback, UroGen's Zusduri gets FDA approval (Shutterstock)

More from Strategy

More from R&D